Hongyu Zhou

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank

Xiaofei Wang, Ziyan Shi, Yuhan Qiu et al. · BMC Medicine · 2024 · 93 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

Tanuja Chitnis, Brenda Banwell, Ludwig Kappos et al. · The Lancet Neurology · 2021 · 81 citations

Medicine, Neurology, Pediatrics +12

Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

Chong Yan, Rui‐Sheng Duan, Huan Yang et al. · Neurology and Therapy · 2022 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques

Daidi Zhao, Hongyu Zhou, Qizhu Wu et al. · NeuroImage · 2011 · 48 citations

Medicine, Neurology, Neuroscience +15